Spirox

company

About

Spirox is a medical device company improving the quality of life for patients suffering from nasal obstruction.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$45M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Spirox is a California-based medical device company improving the quality of life for patients suffering from nasal obstruction. They are formerly known as Nasoform. Their first product, the LATERA absorbable nasal implant is designed to address one of the most common, yet undertreated, causes of nasal obstruction today, nasal valve collapse (NVC).

The company intends to use the funds to complete development, seek US marketing authorization, and initiate product commercialization. Spirox was founded in 2011 and is headquartered in Menlo Park, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$45M
Spirox has raised a total of $45M in funding over 2 rounds. Their latest funding was raised on Mar 15, 2016 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 15, 2016 Series C $45M 1 Kohlberg Kravis Roberts Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Spirox is funded by 1 investors. Kohlberg Kravis Roberts are the most recent investors.
Investor Name Lead Investor Funding Round
Kohlberg Kravis Roberts Yes Series C